Antidepressant use and risk of out-of-hospital cardiac arrest: A nationwide case-time-control study

Clinical Pharmacology and Therapeutics

Volumn 92, Issue 1, 2012, Pages 72-79

  Weeke, P ^a,b   Jensen, A ^c   Folke, F ^a   Gislason, G H ^a   Olesen, J B ^a   Andersson, C ^a   Fosbol E L ^a,d   Larsen, J K ^a   Lippert, F K ^e   Nielsen, S L ^f   Gerds, T ^c   Andersen, P K ^c   Kanters, J K ^c   Poulsen, H E ^g   Pehrson, S ^h   Kober L ^h   Torp Pedersen, C ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e Head Office   (Denmark)

^f Mobile Responsive Care Unit   (Denmark)

^g Mental Health Services CPH   (Denmark)

^h Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; NORADRENERGIC AND SPECIFIC SEROTONERGIC ANTIDEPRESSANT; NORTRIPTYLINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUT OF HOSPITAL CARDIAC ARREST; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CITALOPRAM; DEATH, SUDDEN, CARDIAC; DENMARK; DEPRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORTRIPTYLINE; ODDS RATIO; OUT-OF-HOSPITAL CARDIAC ARREST; RISK ASSESSMENT; TIME FACTORS;

EID: 84862590416     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.368     Document Type: Article

References (45)

1. Lichtman, J.H. et al.; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118, 1768-1775 (2008).
2. Ford, D.E., Mead, L.A., Chang, P.P., Cooper-Patrick, L., Wang, N.Y. & Klag, M.J. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch. Intern. Med. 158, 1422-1426 (1998).
3. Olfson, M. & Marcus, S.C. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66, 848-856 (2009).
4. Association of Danish Pharmacies. Forbruget af lægemidler i 2009 〈http://www.apotekerforeningen.dk/pdf/Analyser2010/Forbruget-af- laegemidler-2009.pdf〉 (2010).
5. Ray, W.A., Meredith, S., Thapa, P.B., Hall, K. & Murray, K.T. Cyclic antidepressants and the risk of sudden cardiac death. Clin. Pharmacol. Ther. 75, 234-241 (2004).
6. Cohen, H.W., Gibson, G. & Alderman, M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am. J. Med. 108, 2-8 (2000).
7. Barbey, J.T. & Roose, S.P. SSRI safety in overdose. J. Clin. Psychiatry 59 (suppl. 15), 42-48 (1998).
8. Glassman, A.H. Cardiovascular effects of antidepressant drugs: updated. J. Clin. Psychiatry 59 (suppl. 15), 13-18 (1998).
9. US Food and Drug Administration. FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) 〈http://www.fda.gov/Drugs/DrugSafety/ucm269086.htm〉(2011).
10. Whang, W. et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J. Am. Coll. Cardiol. 53, 950-958 (2009).
11. Smoller, J.W. et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch. Intern. Med. 169, 2128-2139 (2009).
12. Xiong, G.L. et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am. J. Cardiol. 98, 42-47 (2006).
13. Isbister, G.K., Bowe, S.J., Dawson, A. & Whyte, I.M. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J. Toxicol. Clin. Toxicol. 42, 277-285 (2004).
14. Haverkamp, W. et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur. Heart J. 21, 1216-1231 (2000).
15. Lespérance, F. et al.; CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297, 367-379 (2007).
16. Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A. & Haukka, J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch. Gen. Psychiatry 63, 1358-1367 (2006).
17. Leonard, C.E., Bilker, W.B., Newcomb, C., Kimmel, S.E. & Hennessy, S. Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol. Drug Saf. 20, 903-913 (2011).
18. Hyttel, J., Bøgesø, K.P., Perregaard, J. & Sánchez, C. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. J. Neural Transm. Gen. Sect. 88, 157-160 (1992).
19. Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A. & Rosenthal, R. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 358, 252-260 (2008).
20. Glassman, A.H. et al.; Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288, 701-709 (2002).
21. Sala, M. et al. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr. Opin. Investig. Drugs 7, 256-263 (2006).
22. Priori, S.G. et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur. Heart J. 22, 1374-1450 (2001).
23. Saarto, T. & Wiffen, P.J. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev. 17 October 2007, CD005454 (2007).
24. Barefoot, J.C. & Schroll, M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93, 1976-1980 (1996).
25. Empana, J.P. et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch. Intern. Med. 166, 195-200 (2006).
26. Carney, R.M. et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 104, 2024-2028 (2001).
27. Siscovick, D.S. et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274, 1363-1367 (1995).
28. Vaccarino, V. et al.; National Heart, Lung, and Blood Institute. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J. Am. Coll. Cardiol. 50, 2044-2050 (2007).
29. Hirschfeld, R.M. et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277, 333-340 (1997).
30. Denollet, J., Vaes, J. & Brutsaert, D.L. Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 102, 630-635 (2000).
31. Berkman, L.F. et al.; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289, 3106-3116 (2003).
32. Taylor, C.B. et al.; ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 62, 792-798 (2005).
33. Weeke, P. et al. Pharmacotherapy and hospital admissions before out-of-hospital cardiac arrest: a nationwide study. Resuscitation 81, 1657-1663 (2010).
34. Working group of the Danish Cardiac Arrest Registry. Status report (2005) 〈http://www.sundhed.dk/content/cms/67/1867-aarsrapport-2005- hjertestopregister.pdf〉. Accessed January 2010.
35. Horsted, T.I., Rasmussen, L.S., Meyhoff, C.S. & Nielsen, S.L. Long-term prognosis after out-of-hospital cardiac arrest. Resuscitation 72, 214-218 (2007).
36. Folke, F. et al. Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations. Circulation 120, 510-517 (2009).
37. Gaist, D., Sørensen, H.T. & Hallas, J. The Danish prescription registries. Dan. Med. Bull. 44, 445-448 (1997).
38. Andersen, T.F., Madsen, M., Jørgensen, J., Mellemkjoer, L. & Olsen, J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 46, 263-268 (1999).
39. Charlson, M.E., Pompei, P., Ales, K.L. & MacKenzie, C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373-383 (1987).
40. Deyo, R.A., Cherkin, D.C. & Ciol, M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45, 613-619 (1992).
41. Nuttall, M., van der Meulen, J. & Emberton, M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J. Clin. Epidemiol. 59, 265-273 (2006).
42. Suissa, S. The case-time-control design. Epidemiology 6, 248-253 (1995).
43. Suissa, S. The case-time-control design: further assumptions and conditions. Epidemiology 9, 441-445 (1998).
44. Greedy matching algorithm by Erik Bergstralh and Jon Kosanke (Mayo Clinic) 〈http://mayoresearch.mayo.edu/mayo/research/biostat/upload/gmatch. sas〉. Accessed January 2011.
45. Maclure, M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 133, 144-153 (1991).